0.05Open0.05Pre Close0 Volume162 Open Interest4.00Strike Price0.00Turnover133.39%IV17.36%PremiumJul 19, 2024Expiry Date0.00Intrinsic Value100Multiplier5DDays to Expiry0.05Extrinsic Value100Contract SizeAmericanOptions Type-0.1205Delta0.2558Gamma95.60Leverage Ratio-0.0140Theta-0.0001Rho-11.52Eff Leverage0.0012Vega
CorMedix Stock Discussion
Dow Jones· 4 mins ago. CorMedix: DefenCath Catheter Lock Solution Is FDA Approved to Reduce Incidence of Catheter-Related Bloodstream Infections in Adult Patients With Kidney Failure >CRMD
Dow Jones· 2 mins ago
Benzinga· just
CorMedix Receives FDA Approval For Defencath - moomoo
No comment yet